Mikhail-Petrov-96
Alureon shares (New York Stock Exchange:channel(70% in post-market transactions on Thursday after ending the regular session by 21% due to the news that the company plans to conduct a clinical study of its product to lose weight with gastric balloon in conjunction with the GLP-1 drugs.
Al -Aurion (
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/654548316/image_654548316.jpg?io=getty-c-w750
Source link